Written Disclosure Therapy for Anxiety and Stress in Patients With Chronic Lung Disease

Not Applicable

Completed

• Conditions: Chronic Lung Diseases; COPD; Pulmonary Fibrosis
• Interventions: Other: Neutral (Sham) Writing; Other: Disclosure Writing (Written Disclosure Therapy)

• Registration Number: NCT00911794
• Lead Sponsor: Winthrop University Hospital

Brief Summary

The purpose of this study is to determine whether Written Disclosure Therapy (WDT) is of any benefit to patients with chronic lung diseases who are participating in pulmonary rehabilitation.

Detailed Description

Chronic lung diseases are typically associated with impaired quality of life, stress, and anxiety. Written disclosure therapy (WDT) reduces stress in patients with a variety of chronic illnesses. We sought to determine if written disclosure therapy benefits patients with chronic lung diseases when it is added as a component to the pulmonary rehabilitation program.

Study Timeline

• Study Start: 2007-01
• Primary Completion: 2008-01
• Study Completion: 2009-03
• Study First Submitted: 2009-05-29
• Status Verified: 2009-06
• Study First Submitted QC: 2009-06-01
• Last Update Submitted: 2009-06-01
• Study First Posted: 2009-06-02
• Last Update Posted: 2009-06-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 66

Inclusion Criteria

• Diagnosis of COPD or Pulmonary Fibrosis
• First time participants in Pulmonary Rehabilitation program

Exclusion Criteria

• Dementia
• Prior significant psychiatric illness
• Inability to complete the questionnaires
• Inability cooperate with spirometry
• Inability or to participate in outpatient follow-up over the six-month

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Controls	Neutral (Sham) Writing	-
Written Disclosure Therapy	Disclosure Writing (Written Disclosure Therapy)	-

Primary Outcome Measures

Name	Time	Method
Dyspnea and quality of life	Two-month and six-month time

Secondary Outcome Measures

Name	Time	Method
Six-minute walk distance	Two-month and six-month time
Spirometry values (FEV1 and FVC)	Two-month and six-month time